Completion of the Share Capital Decrease the Jordanian Pharmaceutical Manufacturing Co.
Ref. : 10955/2024
Date: 18/12/2024
Memo No.
(86/2024)
Members of SDC of Brokers and Custodians
Dear General Manager,
Subject: Completion of the Share Capital Decrease the Jordanian Pharmaceutical Manufacturing Co.
Greetings,
Kindly be informed that the SDC has completed the process of decreasing the share capital of the Jordanian Pharmaceutical Manufacturing Company on Wednesday 18/12/2024 to redeem the balance of accumulated losses as of 31/12/2023.
The above-mentioned procedure is conducted based upon the company's General Assembly's resolution made in its extraordinary meeting held on 30/10/2024 which was granted the approval of the Ministry of Industry, Trade, and Supply on 12/12/2024.
Thereby, the SDC record for the Capital of the Jordanian Pharmaceutical Manufacturing Company indicates the following:
| # | Company Name | No. of shares decreased | Registered Share Capital |
ISIN
|
Company No. |
| 1. | Jordanian Pharmaceutical Manufacturing Co. | 36,058,854 | 33,698,090 | JO4120411015 | 141204 |
Kind Regards,
Sarah Tarawneh
Chief Executive Officer
